Petition · HM Treasury
Prohibit short-selling on companies developing life-saving treatment
Closed
138 signatures
What the petition asks
We the undersigned, call on Parliament to ban the practice of short-selling publicly traded British companies actively engaged in the research and development of treatments for cancer and other life-threatening disorders.
The British biotech sector plays a critical role in advancing healthcare, with companies often investing significant time, capital and intellectual resources into developing novel and transformative treatments for conditions like acute myeloid/lymphoblastic leukaemias and other cancers that have been historically hard to treat. We believe that short-selling damages their ability to complete vital research in the area.
Timeline
| 14 Feb 2025 | Petition opened for signatures |
| 14 Aug 2025 | Closed to new signatures |
Key facts
Signatures
138
Status
Closed
Department
HM Treasury
Opened
14 Feb 2025
Closed
14 Aug 2025
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 10 Aug 2026.